Fortive Corporation · NYSE:FTV
Fortive — Q3 2026 Earnings Presentation
22 slides from Fortive's earnings presentation, Oct 28, 2026
Slide 1: Third Quarter 2026 Earnings
Third Quarter 2026 Earnings EARNINGS PRESENTATION October 28, 2026
Slide 2: Forward Looking Statements and Non-GAAP Financial Measures
Forward Looking Statements and Non-GAAP Financial Measures FORWARD-LOOKING STATEMENTS Statements in this presentation that are not strictly historical, including statements regarding anticipated financial results, global and regional economic conditions, industry trends, geopolitical events, anticip
Slide 3: Key Messages
Key Messages 1 Strong Q3 financial performance and execution by Fortive team, delivering +7.2% core growth, ~10% adjusted EBITDA growth and ~13% adjusted EPS growth Deployed ~$300 million to share repurchases in Q3, bringing total share repurchases since the launch of new 2 Fortive to ~$2.3 billion,
Slide 4: Fortive Accelerated Strategy
Fortive Accelerated Strategy 1 2 3 Faster Profitable Disciplined Capital Build and Maintain Organic Growth Allocation Investor Trust • Innovation Acceleration • Invest in organic growth • Clear expectations and consistent • Commercial Acceleration • Smaller bolt-on M&A delivery n • Simplified guidan
Slide 5: Fortive Results
Fortive Results Q3 2026 COMMENTARY • Core revenue growth of +7.2%, led by Q3 2026 strong performance in IOS segment Revenue $1,107.5M • Adj. Gross Margin of 62.5%, down ~80 bps Reported Growth +7.8% year-over-year, driven primarily by product Core Growth +7.2% mix, partially offset by operating leve
Slide 6: Intelligent Operating Solutions
Intelligent Operating Solutions Q3 2026 COMMENTARY Q3 2026 • Core revenue growth of +9.1%, driven by acceleration in professional Revenue $767.1M instrumentation, Facilities and Asset Reported Growth +9.8% Lifecycle solutions and gas detection Core Growth +9.1% • Adj. Gross Margin of ~65%, similar t
Slide 7: Advanced Healthcare Solutions
Advanced Healthcare Solutions Q3 2026 COMMENTARY Q3 2026 • Core revenue growth of +3.1%, driven by solid demand for healthcare Revenue $340.4M consumables and SaaS offerings, with Reported Growth +3.7% modest growth in capital equipment Core Growth +3.1% • Adj. Gross Margin of ~58%, down about 90 bp
Slide 8: Balance Sheet & Capital Allocation
Balance Sheet & Capital Allocation Q3 2026 COMMENTARY & CAPITAL ALLOCATION Balance Sheet As of October 2, 2026 HIGHLIGHTS Cash and equivalents $0.38B • Deployed ~$300 million towards share repurchase in Q3, representing ~5M Gross Debt, principal amounts $3.53B shares, at an average price of $60.14 N
Slide 9: Raising FY 2026 Guidance
Raising FY 2026 Guidance Adj. EPS | FY 2026 $3.10 to $3.14 Guidance as of date of Q3 2026 earnings call: October 28, 2026. 9
Slide 10: Fortive Accelerated
Fortive Accelerated Innovating essential technologies to keep our world safe and productive 10
Slide 11: Appendix & Supplemental Reconciliation Data
Appendix & Supplemental Reconciliation Data 11
Slide 12: Core Revenue Growth and Revenue by Geography
CORE REVENUE GROWTH AND REVENUE BY GEOGRAPHY Three Months Ended October 2, 2026 Intelligent Advanced Operating Healthcare Total Fortive Solutions Solutions Total revenue growth (GAAP) 9.8 % 3.7 % 7.8 % Excluding impact of: Acquisitions and divestitures (0.4)% (0.5)% (0.5)% Currency exchange rates (0
Slide 13: Adjusted Gross Profit and Adjusted Gross Profit Margin
ADJUSTED GROSS PROFIT AND ADJUSTED GROSS PROFIT MARGIN Three Months Ended October 2, 2026 Three Months Ended September 26, 2025 $ in millions Intelligent Advanced Intelligent Advanced Operating Healthcare Total Operating Healthcare Total Solutions Solutions Fortive Solutions Solutions Fortive Revenu
Slide 14: Adjusted EBITDA and Adjusted EBITDA Margin from Continuing Operations
ADJUSTED EBITDA AND ADJUSTED EBITDA MARGIN FROM CONTINUING OPERATIONS Three Months Ended $ in millions October 2, 2026 July 3, 2026 April 3, 2026 December 31, 2025 September 26, 2025 Revenue (GAAP) $ 1,107.5 $ 1,096.8 $ 1,069.4 $ 1,122.5 $ 1,027.1 Net Earnings from Continuing Operations (GAAP) $ 172
Slide 15: Operating Profit to Adjusted EBITDA Bridge
OPERATING PROFIT & OPERATING PROFIT MARGIN TO ADJUSTED EBITDA AND ADJUSTED MARGIN BRIDGE Three Months Ended $ in millions October 2, 2026 September 26, 2025 Revenue (GAAP) $ 1,107.5 $ 1,027.1 Operating Profit (GAAP) $ 235.9 $ 159.6 Amortization of acquisition-related intangible assets 89.3 91.5 Acqu
Slide 16: Segment Adjusted EBITDA and Segment Adjusted EBITDA Margin
SEGMENT ADJUSTED EBITDA AND SEGMENT ADJUSTED EBITDA MARGIN Three Months Ended October 2, 2026 Three Months Ended September 26, 2025 $ in millions Intelligent Advanced Unallocated Total Intelligent Advanced Unallocated Total Operating Healthcare Corporate Fortive Operating Healthcare Corporate Fortiv
Slide 17: Adjusted Net Earnings and Adjusted Diluted EPS
ADJUSTED NET EARNINGS AND ADJUSTED DILUTED EPS FROM CONTINUING OPERATIONS Three Months Ended $ in millions, except per share amounts October 2, 2026 September 26, 2025 Per share Per share value value Net Earnings and Earnings Per Share from Continuing Operations (GAAP) $ 172.5 $ 0.57 $ 117.0 $ 0.35
Slide 18: Debt Principal, Net Debt, and Leverage
DEBT PRINCIPAL, NET DEBT, AND LEVERAGE $ in millions October 2, 2026 Current portion of long-term debt, carrying value $ — Long-term debt, carrying value 3,514.2 Debt, net carrying value (GAAP) 3,514.2 Plus: Aggregate unamortized debt discounts, premiums, and issuance costs 17.8 Debt, principal amou
Slide 19: Free Cash Flow from Continuing Operations
FREE CASH FLOW FROM CONTINUING OPERATIONS Three Months Ended Trailing Twelve $ in millions October 2, 2026 July 3, 2026 April 3, 2026 December 31, 2025 Months Operating Cash Flows from Continuing Operations (GAAP) $ 313.3 $ 298.7 $ 220.4 $ 344.2 $ 1,176.6 Less: Purchases of property, plant & equipme
Slide 20: Adjusted P&L
ADJUSTED P&L Three Months Ended October 2, 2026 Intelligent Operating Solutions Advanced Healthcare Solutions Unallocated Corporate Costs & Other Total Fortive $ in millions, except per share amounts Adjust- Adjusted Adjust- Adjusted Adjust- Adjusted Adjust- Adjusted GAAP ments (Non-GAAP) GAAP ments
Slide 21: Adjusted P&L
ADJUSTED P&L Three Months Ended September 26, 2025 Intelligent Operating Solutions Advanced Healthcare Solutions Unallocated Corporate Costs & Other Total Fortive $ in millions, except per share amounts Adjust- Adjusted Adjust- Adjusted Adjust- Adjusted Adjust- Adjusted GAAP ments (Non-GAAP) GAAP me
Slide 22: @ FORTIVE ©Fortive2026 ©
@ FORTIVE ©Fortive2026 © 22